Menopausal and female climacteric states.
Conditions
Interventions
Intervention 1: Intervention groups one: The first group of 30 mg capsules of fennel extract for two months and orally twice a day. Intervention 2: Intervention group two: 1000 mg capsules of evening
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 60 Years
Inclusion criteria
Inclusion criteria: Lack of surgery in ovarian tumors Not getting breast cancer treatment (hormone therapy) Failure to receive HRT Women aged 45 to 60 years
Exclusion criteria
Exclusion criteria: Sudden increase or decrease of weight in the sample Any reason that increases or decreases the level of estrogen in the body For any reason, a person has to have hormone therapy Any sign indicating that allergy to fennel and evening primrose oil has manifested itself Examples that can cause menstrual disorder for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Menopause symptoms. Timepoint: Before intervention, two months after the intervention. Method of measurement: Hormones, SF36 General Measurement of Quality of Life, MRS A tool for assessing the severity of postmenopausal women's symptoms. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hormonal changes. Timepoint: Before intervention, two months after the intervention. Method of measurement: Elisa Methode.;Evaluation of the quality of life of postmenopausal women. Timepoint: Before intervention, two months after the intervention. Method of measurement: A general tool for assessing the quality of life SF36.;Evaluation of severity of symptoms of postmenopausal women. Timepoint: Before intervention, two months after the intervention. Method of measurement: A special tool for assessing the severity of symptoms of postmenopausal women MRS. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGhavi Fatemeh
Shiraz University of Medical Sciences
Outcome results
None listed